Leadership Team

Tony has a DPhil from Oxford in Chemistry and 30 years commercial experience in pharmaceutical development including work in Astra Zeneca Oncology, at MerckSerono and as CEO of Vifor Pharma. He led the commercial development of Iressa for lung cancer and has wide experience working with oncology start-up companies, in Board roles and as a consultant. Tony has previously held roles in the NHS and as a Trustee for a lung cancer charity.

After graduating from Oxford in Biochemistry William has over 34 years experience in the Biotech sector with a particular focus on leading SMEs. Previous companies include R&D Systems, Amersham International, British Biotech and Beckman Coulter alongside small start-ups following outsourcing strategies where relevant.

Professor Jiang is a globally renowned immunologist from Oxford University with previous experience at the Dana Farber Cancer Institute in the USA. He pioneered the concept of Recombinant Overlapping Peptides as therapeutic vaccines and has led all the development work vested in the company. He has a strong record in translational science, with both therapeutics and diagnostics in clinical trials, and holds a Senior Industrial Fellowship at the University of Oxford.